Randomized Control Study Evaluating Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP)
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
This is a study evaluating the usage of Ketamine as sedative agent in ERCP. The usage of Ketamine will be compared to the standard sedation in our center, which is Midazolam in combination with Pethidine as analgesia.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Healthy Volunteers: t
View:
• Malaysian citizens of who is able to give valid consent
• Patient planned for ERCP (either emergency or elective)
Locations
Other Locations
Malaysia
University Kebangsaan Malaysia Medical center
RECRUITING
Bandar Tun Razak
Contact Information
Primary
Muhammad Hafiz Ismail, MBBS
muhdhafizismail88@gmail.com
6016 3354384
Backup
Ian Chik, MD
ianchikmd@gmail.com
6012 3243404
Time Frame
Start Date: 2020-03-01
Estimated Completion Date: 2021-04-30
Participants
Target number of participants: 140
Treatments
No_intervention: Midazolam group
Standard sedation for ERCP in UKMMC
Experimental: Ketamine group
Related Therapeutic Areas
Sponsors
Leads: Universiti Kebangsaan Malaysia Medical Centre